COMMUNIQUÉ DE PRESSE
News
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
1upHealth Launches Customer Advisory Board to Advance Industry-Wide Interoperability and Fuel Technological Innovation
1upHealth forms Customer Advisory Board (CAB) with executives from leading health plans to enhance company solutions and drive industry innovation. The CAB will advise on business strategies and product roadmap for optimizing interoperability -
-
COMMUNIQUÉ DE PRESSE
Two Investigator-Initiated Responder Analysis Trials of Jaguar Health's Crofelemer Show Significant Positive Results for Chronic Refractory Diarrhea in IBS-D: Data Accepted for Presentation at American College of Gastroenterology 2024 Annual Meeting
Napo Pharmaceuticals announced positive results of studies on crofelemer for chronic refractory diarrhea at the ACG Annual Scientific Meeting. The drug may benefit patients with functional diarrhea and chronic idiopathic diarrhea -
COMMUNIQUÉ DE PRESSE
Berentzen-Gruppe Aktiengesellschaft publishes preliminary results for the first half of the year
Berentzen-Gruppe Aktiengesellschaft reports a 55% increase in consolidated operating profit (EBIT) to EUR 5.1 million for the first half of 2024, with significant growth attributed to profitability strategy and successful marketing -
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Berentzen-Gruppe Aktiengesellschaft: Group Half-Yearly Financial Report 2024 / Preliminary business figures as of June 30, 2024 / Update of the forecast for the 2024 financial year / Advanced negotiat
Berentzen-Gruppe Aktiengesellschaft expects increased profits for the first half of 2024, updates forecast for the year, and announces negotiations for the sale of a site in Non-alcoholic Beverages segment -
